On October 22, 2026, the U.S. Food and Drug Administration (FDA) issued its final mandatory cosmetic recall guidance. The guidance explains how FDA will exercise the authority granted by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). Its publication creates no new compliance deadline. For companies selling cosmetics in the United States, the critical distinction is between FDA's written notice offering an opportunity to act voluntarily and an order requiring the responsible person to stop distribution immediately. A mandatory recall may follow through a separate procedural step.
Quick Navigation
Scope and risk threshold Responsible person Recall procedure Recall preparation How REACH24H Can HelpWhen does the FDA mandatory cosmetic recall guidance apply?
Under section 611 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), FDA must find a reasonable probability that both of the following conditions are met:
The cosmetic is adulterated under section 601 or misbranded under section 602 of the FD&C Act.
Using the cosmetic or being exposed to it will cause serious adverse health consequences or death.
A misleading label may establish misbranding. To invoke section 611, FDA must also assess the likely health consequences of use or exposure. The agency may consider inspection findings, laboratory results, consumer complaints, serious adverse event reports, and the vulnerability of the people who use the product. A serious adverse event report can inform that assessment, but FDA must evaluate the circumstances and available evidence against both statutory conditions.
Product classification also matters. Cosmetics that are also subject to the drug or device requirements in Chapter V of the FD&C Act fall outside section 611. Other mandatory recall authorities may apply to those products.
Who is the responsible person for an imported cosmetic?
The responsible person is the manufacturer, packer, or distributor whose name appears on the cosmetic product label in accordance with the applicable U.S. labeling provisions. For example, if a European contract manufacturer produces a private-label cosmetic and the U.S. label identifies the distributor as the business responsible for the product, that distributor is the responsible person. The manufacturer may still hold the batch records and test results the distributor needs to investigate a complaint. FDA's recall policy for cosmetics explains how the agency identifies the responsible person.
How does FDA proceed from voluntary action to a mandatory recall?
Written notice and opportunity for voluntary action. Once FDA determines that the statutory threshold is met, it must give the responsible person an opportunity to stop distribution and recall the cosmetic voluntarily. FDA states that it will provide written notice and may specify when and how the responsible person is to act.
Order to stop distribution. If the responsible person refuses or fails to act within the time and in the manner FDA prescribes, FDA may issue an order requiring distribution to stop immediately. The responsible person must comply upon receipt. FDA may also require notice to affected manufacturers, distributors, importers, sellers, or the public.
Opportunity for an informal hearing. FDA must give the responsible person an opportunity to challenge whether the evidence justifies the order. If granted, the hearing must take place no later than 10 days after FDA issues the stop-distribution order. The 10-day period applies to the hearing. Distribution must stop immediately and remain suspended while the order is in force.
Decision on the order. After providing the hearing opportunity, FDA must withdraw the order if the grounds are inadequate, continue the distribution halt until a specified date, or amend the order to require a recall. A recall order may specify whom to notify, the recall timetable, and when the responsible person must report progress to FDA.
If FDA orders a recall, it will ensure that a press release identifies the product and describes the risk. FDA generally terminates the recall once it determines that the requirements of the order have been met and provides written notice to the recalling firm. Failure to comply with a section 611 order is a prohibited act and may result in an injunction or criminal prosecution.
How can companies prepare for a potential recall?
A mock recall is one way to assess readiness. Companies can schedule an exercise according to product risk and existing procedures. The final guidance sets no deadline for conducting a drill or revising quality agreements.
For brands that rely on contract manufacturing or third-party distribution, an exercise can focus on three questions:
Who can halt shipments? Identify the responsible person from the U.S. label and confirm who can authorize a hold and communicate it to warehouses, distributors, and retailers.
Can the responsible person assess a reported injury? Select a complaint and check whether the team can retrieve the relevant batch records, test results, and MoCRA safety substantiation documentation. Record what happened, who used the product, and which evidence the manufacturer or distributor still needs to provide.
Can the company trace an affected lot? Select a lot already in U.S. distribution. Check whether shipment records identify recipients and quantities, whether contact information is current, and how the team would track responses and account for affected units.
How REACH24H Can Help
REACH24H supports manufacturers, brands, and distributors with U.S. cosmetic label and formula reviews, safety substantiation, and toxicological risk assessments. If your distributor is named on the U.S. label and your contract manufacturer maintains the technical records, our team can review the label and assess whether the available documentation supports the safety of the product as marketed.
Discuss your U.S. cosmetics compliance needs with REACH24H
Contact Us Explore U.S. Cosmetics Services
